Science Stories
Our R&D team chases bold goals. The therapies and solutions that no one else has achieved or even attempted. And we want to be there first. That's what we go after every day for our patients.
-
Real-World Evidence Shapes Innovation in IBD Research
How real-world evidence is reshaping our understanding of IBD and driving innovative approaches to research and development.
Read Article -
Genetic medicine and AbbVie’s role in research
Q&A: Hacking genetic information to treat disease.
Read Article -
Three ways AI is changing drug discovery at AbbVie
Explore how we harness the power of AI to find new treatments for diseases with large unmet need.
Read Article -
Can We Find Cures Faster?
Learn how AbbVie researchers find and advance ideas that have the potential to cure.
Read Article -
Elevating health care for all
See how AbbVie goes beyond the numbers to increase representation in clinical trials.
Read Article -
Specialized Research in Chaotic Systems (SPaRCS)
Watch how AbbVie’s Specialized Research in Chaotic Systems (SPaRCS) team is breaking barriers to advance the development of new therapies.
Read Article -
AbbVie Research Collaborative
Watch how we are working to harness technology, data and real-life experiences to create the medicines of the future.
Read Article -
Digital Science Lab: Reshaping Clinical Research With Technology
Scientist Michelle Crouthamel describes how her lab integrates biosensors and wearables to bring clearer insights about medicine we’re developing.
Read Article -
Meet the ARCH, a time-saving tool for researchers focused on finding cures
An inside look at the creation of a search engine to help solve science’s toughest questions.
Read Article -
5 ways AbbVie is working to deliver medicines in half the time
When it comes to creating more time for patients with debilitating diseases, AbbVie’s goals are ambitious—and they need to be.
Read Article -
What does it take to discover a new medicine?
In oncology, immunology, virology and beyond, researchers strive to turn science into breakthrough medicines. See how in AbbVie’s Discovery Files series.
Read Article -
Green initiatives helping AbbVie grow sustainably
In R&D, operations and beyond, employees do what’s good for patients, people and the planet
Read Article -
Why isn’t medicine one size fits all?
Precision medicine explained: Breaking down how this unique approach and commitment could fundamentally change how we treat disease.
Read Article -
Unlocking the next level of protein degradation
What have we learned about degradomers?
Read Article -
Can unlocking one million genomes help us discover medicines faster?
With the most complete human genome sequenced yet, AbbVie’s Genomics Research Center aims to find out.
Read Article -
Our approach to data science and analytics
Get an inside look at our largest data initiative
Read Article -
They won’t back down
5 courageous voices on why investment in new medicines matters.
Read Article -
Helping women succeed in STEM
5 ways to be an ally for women in science
Read Article -
The story behind our $50 billion R&D investment
Discovering and developing new medicines is not easy. But it’s an aspiration that drives our science and is the foundation of this company.
Read Article -
Stronger together: A convergence of minds and data
Data convergence is anything but dull when you pair a veteran data scientist with a leader who connected human genome reading to clinical care.
Read Article -
Inside the world of human factors engineers
Meet the team whose job is to solve problems before they exist
Read Article -
How uterine fibroids feel to a patient…who’s also a doctor
An AbbVie researcher shares how her own struggles with uterine fibroids influenced her perspective as a doctor and scientist.
Read Article -
Advice from a scientist turned physician turned robot builder -- be curious
Why science is a team sport and failure isn’t all bad, says AbbVie’s new Chief Scientific Officer.
Read Article -
Why you can’t wait with rheumatoid arthritis
Why is it important for people to see a rheumatologist sooner rather than later?
Read Article -
How patient voices are changing medicine
An AbbVie leader in patient-centered research helps us to hear and consider the patient voice.
Read Article -
Green chemistry
What's the impact from cleaner, faster chemical reactions?
Read Article -
Synthetic control arm: the end of placebos?
Although randomization may always be the gold standard, Big Data is breathing new life into clinical trial design.
Read Article -
A molecular behavior chart: speeding up research with predictive analytics
Whether a molecule acts like a “lobster” or “crayfish” may predict its ability to one day become a medicine.
Read Article -
ChemBeads: Improving artificial intelligence through human ingenuity
Discovering a new medicine isn’t easy. When robots couldn’t help, three scientists found a way.
Read Article -
Striving for patient centricity, down to the packaging
Understand the future of packaging and how it’s evolving to be more about the patient.
Read Article -
The blueprint of you: Unlocking the potential of whole genome sequencing
A genetic pioneer reveals what he learned from mapping his own genome.
Read Article -
Chasing the value of a walk down the aisle
Can you quantify the value of moments that matter? How patient experiences change the equation.
Read Article -
Real-world data rounds out value picture of drugs
Medical records and insurance claims data help companies, regulators, payers and physicians better understand how medicines perform in the real world.
Read Article
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2025 AbbVie Inc. North Chicago, Illinois, U.S.A.
